Why menstrual blood does not clot

Reading File

Finding Sources

Searching PubMed

menstrual blood fibrinolysis coagulation mechanism

Finding Sources

Reading Article

PMID: 12753939

Reading Article

PMID: 8796825

Reading File

Finding Sources

Now I have enough information to give a thorough, well-sourced answer. Here is the complete explanation:

Why Menstrual Blood Does Not Clot

Menstrual blood is unique - it does not clot under normal circumstances because of a carefully regulated biological process involving local fibrinolysis, anti-coagulant activity, and tissue breakdown triggered by progesterone withdrawal.

1. The Trigger: Progesterone Withdrawal

When pregnancy does not occur, the corpus luteum degenerates around day 20-22 of the cycle. This causes a rapid fall in progesterone (and estrogen). Progesterone withdrawal is the key event that initiates the entire cascade.

Medical Physiology (Boron & Boulpaep), p. 1622: "Withdrawal of progesterone (and estrogen) due to the demise of the corpus luteum leads to degeneration and shedding of the superficial part of the endometrium known as the functional layer."

2. The Main Anti-Clotting Mechanisms

a) Increased Fibrinolysis (the primary reason)

Progesterone normally suppresses fibrinolytic activity. When progesterone withdraws:

Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) are upregulated in endometrial stromal cells.
These enzymes convert plasminogen to plasmin, which actively digests fibrin clots.
At the same time, PAI-1 (Plasminogen Activator Inhibitor-1, which normally blocks tPA/uPA) is markedly reduced.

This shift means that any fibrin clot that begins to form is almost immediately dissolved by locally produced plasmin. As described by Lockwood & Schatz (1996): "Progesterone withdrawal reduces TF and PAI-1 expression and increases tPA, uPA...accounting for the hemorrhage and enhanced fibrinolysis characterizing menstruation."

b) Reduced Tissue Factor (TF)

Tissue factor is the initiator of the extrinsic coagulation cascade. During the luteal phase, progesterone upregulates TF in decidualized stromal cells (this protects against hemorrhage during implantation). After progesterone withdrawal, TF expression falls sharply, reducing the stimulus for clot formation in the first place.

c) Matrix Metalloproteinases (MMPs)

Progesterone withdrawal also increases MMPs, which degrade the extracellular matrix. This facilitates tissue breakdown and further disrupts any structural framework that might support clot formation.

d) Prostaglandins and Vasoconstriction

Spiral arterioles constrict due to prostaglandins (especially PGF2α), causing ischemia and necrosis. The necrotic endometrial tissue contains lysosomal proteolytic enzymes that are released and contribute to degrading the tissue - including any nascent clots.

3. The Net Effect

In Normal Blood	In Menstrual Blood
Clotting factors activate	Tissue factor reduced
Fibrin mesh forms	Fibrinolysis (plasmin) dissolves fibrin
PAI-1 stabilizes clots	PAI-1 suppressed
Stable clot result	Fluid, non-clotting blood

4. When Clots Do Appear

Paradoxically, if menstrual flow is very heavy (e.g., in menorrhagia), clots can appear. This happens because the rate of bleeding outpaces the fibrinolytic system - the volume of blood is so high that plasmin cannot dissolve all the fibrin before it consolidates. So clots during menstruation are actually a sign of abnormally heavy flow.

Summary

Menstrual blood stays liquid because progesterone withdrawal upregulates tPA/uPA and suppresses PAI-1 in the endometrium, massively increasing local fibrinolytic activity. Fibrin clots are broken down almost as fast as they form. This is an evolved mechanism to allow smooth, complete shedding of the endometrial lining rather than a plug forming inside the uterus. - Ferenczy, Maturitas 2003 | Lockwood & Schatz, J Soc Gynecol Investig 1996

This is a shared conversation. Sign in to Orris to start your own chat.